Your browser doesn't support javascript.
loading
Exploration of alive-and-ventilator free days as an outcome measure for clinical trials of Resuscitative interventions.
Moskowitz, Ari; Xie, Xianhong; Gong, Michelle Ng; Wang, Henry E; Andrea, Luke; Lo, Yungtai; Kim, Mimi.
Afiliação
  • Moskowitz A; Division of Critical Care Medicine, Montefiore Medical Center, The Bronx, NY, United States of America.
  • Xie X; Bronx Center for Critical Care Outcomes and Resuscitation Research, Montefiore Medical Center, The Bronx, NY, United States of America.
  • Gong MN; Department of Epidemiology and Population Health, Einstein Medical School, the Bronx, New York, United States of America.
  • Wang HE; Division of Critical Care Medicine, Montefiore Medical Center, The Bronx, NY, United States of America.
  • Andrea L; Department of Emergency Medicine, The Ohio State University, Columbus, Ohio, United States of America.
  • Lo Y; Division of Critical Care Medicine, Montefiore Medical Center, The Bronx, NY, United States of America.
  • Kim M; Bronx Center for Critical Care Outcomes and Resuscitation Research, Montefiore Medical Center, The Bronx, NY, United States of America.
PLoS One ; 19(7): e0308033, 2024.
Article em En | MEDLINE | ID: mdl-39083542
ABSTRACT

BACKGROUND:

Outcome selection is a critically important aspect of clinical trial design. Alive-and-ventilator free days is an outcome measure commonly used in critical care clinical trials, but has not been fully explored in resuscitation science.

METHODS:

A simulation study was performed to explore approaches to the definition and analysis of alive-and-ventilator free days in cardiac arrest populations. Data from an in-hospital cardiac arrest observational cohort and from the Pragmatic Airway Resuscitation Trial were used to inform and conduct the simulations and validate approaches to alive-and-ventilator free days measurement and analysis.

FINDINGS:

Alive-and-ventilator-free days is a flexible outcome measure in cardiac arrest populations. An approach to alive-and-ventilator free days that assigns -1 days when return of spontaneous circulation is not achieved provides a wider distribution of the outcome and improves statistical power. The optimal approach to the analysis of alive-and-ventilator free days varies based on the expected impact of the intervention under study on rates of return of spontaneous circulation, survival, and ventilator-free survival.

CONCLUSIONS:

Alive-and-ventilator free days adds to the armamentarium of clinical trialists in the field of resuscitation science.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Respiração Artificial / Parada Cardíaca Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Respiração Artificial / Parada Cardíaca Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos